Allegations that Boston Scientific Corp.’s surgical mesh, used in gynecological operations, may contain counterfeit raw material are being examined by U.S. regulators.
The company is performing tests on the raw materials in question to determine if they will have any impact on the safety and effectiveness of the finished product, the U.S. Food and Drug Administration said in a statement on its website. The agency said it’s not aware of any harm that may stem from the allegedly counterfeit material.
